Global Animal Model Market Set to Surge: Key Factors Driving Growth Amidst Pandemic Challenges | CAGR of 6.6% from 2023 to 2032.

The growth of the animal model market is driven by several key factors, including the increasing usage of animal models in virology and infectious diseases research, the physiological similarities between humans and animals for drug testing, and the rising adoption of CRISPR technology.

According to a report, the global animal model market was valued at $1.9 billion in 2022 and is projected to reach $3.6 billion by 2032, with a compound annual growth rate (CAGR) of 6.6% from 2023 to 2032.

Request Sample of the Report: https://www.alliedmarketresearch.com/request-sample/8311

The growth of the global animal model market is attributed to factors such as the rise in the usage of animal models in virology and infectious diseases, the physiological similarity of humans and animals for drug testing, and the increase in adoption of CRISPR technology. On the other hand, the availability of alternative testing methods to restrain market growth during the forecast period. Moreover, high growth potential in emerging markets is anticipated to present significant opportunities for market growth during the forecast period. 

Animal models are crucial for conducting pathological and biological experiments. They mimic human physiological and organic structures, making them invaluable for studying diseases, testing drugs, and developing new products. Animal models find applications in drug discovery and development, basic research, and testing the safety and efficacy of new drugs before human trials.

The COVID-19 pandemic has had both positive and negative impacts on the animal model market:

Positive Impacts:

Increased Research Activity: The urgency to understand, prevent, and treat COVID-19 led to a surge in research activity, boosting the demand for various animal models.
Focus on Emerging Models: Limitations of traditional models highlighted the need for more relevant models like humanized mice and organ-on-a-chip technology, driving research and development in these areas.

Collaboration and Knowledge Sharing: The pandemic fostered collaboration among researchers, clinicians, and animal model experts, accelerating research progress.

Negative Impacts:

Supply Chain Disruptions: Lockdowns and travel restrictions disrupted the supply chain for animals and research materials, leading to shortages and project delays.

Ethical Concerns and Regulatory Challenges: Intense focus on COVID-19 research raised concerns about animal welfare and ethical use in research.

Financial Strain on Institutions: Economic impacts of the pandemic led to budget cuts and funding uncertainties, affecting access to resources for researchers.

The growth of the animal model market is also hindered by the availability of alternative testing methods. However, emerging markets present significant growth opportunities during the forecast period.

Procure Complete Report at:

https://www.alliedmarketresearch.com/checkout-final/animal-model-market

Key Market Segments:

Animal Type: Rat, Mice, Guinea pigs, Rabbits, Others
Application: Drug discovery and development, Basic research, Others
End User: Pharma and biotech companies, Academic research institutes, Others
Region: North America, Europe, Asia-Pacific, LAMEA

Key Findings of the Study:

Mice segment held the largest market share in 2022.
Drug discovery & development segment dominated in 2022.
Pharma & biotech companies were the largest end users in 2022.

North America held the highest market share in 2022, with Asia-Pacific expected to exhibit the fastest growth.

Leading Market Players:

Hera Biolabs, Crown Bioscience Inc., Janvier Labs LLC, Inotiv Inc., Charles River Laboratories, The Jackson Laboratory, Genoway S.A., Trans Genic Inc., Ozgene Pty Ltd., Taconic Biosciences.

For Purchase Inquiry:

https://www.alliedmarketresearch.com/purchase-enquiry/8311

Regional Analysis:

North America dominated the market in 2022, while Asia-Pacific is expected to witness the fastest growth due to a well-developed vaccine industry and high R&D activity.

Contact :

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.